Clinico-Pathologic Profile and Treatment Outcomes of Patients with Diffuse Large B Cell Lymphoma Based on Cell of Origin Classification

Diffuse large B cell lymphoma (DLBCLs) constitute 40% of all non-Hodgkin lymphoma and it represent a heterogeneous group of neoplasms rather than a single clinicopathological entity. We analysed the outcomes and clinical features based on the cell of origin in a series of patients with DLBCL from ou...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Hematol Blood Transfus
Autors principals: Mandloi, Sohan Singh, Thumaty, Divya Bala, Nisha, Yadav, Kayal, Smita, Ganesan, Prasanth, Jacob, Sajini Elizabeth, Basu, Debdatta, Dubashi, Biswajit
Format: Artigo
Idioma:Inglês
Publicat: Springer India 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012439/
https://ncbi.nlm.nih.gov/pubmed/33867728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01322-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars